Drug Type TCR-T Cell therapy |
Synonyms- |
Target |
Action stimulants, inhibitors |
Mechanism CD8 stimulants(Cluster of differentiation 8 stimulants), PRAME inhibitors(PRAME nuclear receptor transcriptional regulator inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 28 Apr 2025 |